BMGL

Basel Medical Group Ltd Ordinary Shares (BMGL) ESG Analysis Analysis (2026)

Invetso Score: 6.1/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Environmental

Score: 5.2 (Moderate)

Basel Medical Group’s environmental risk profile is moderate. While its core operations are not resource-intensive and it is pursuing supply chain efficiencies, the absence of formal climate commitments and limited transparency constrain its environmental score relative to leading peers.

Social

Score:

Basel Medical Group demonstrates strong social performance, driven by its role in expanding healthcare access, maintaining a skilled workforce, and building robust stakeholder relationships. These factors position the company well for continued growth and positive community impact.

Governance

Score:

Governance practices at Basel Medical are moderate. The company benefits from experienced leadership and prudent financial management, but limited ESG disclosure and formalization of governance policies constrain its score compared to global healthcare leaders.

Overall Score

Score:

Basel Medical Group’s ESG profile is moderate overall. The company excels in social impact and workforce quality, with prudent governance and a low direct environmental footprint. However, the absence of formal climate strategies and limited ESG transparency are material gaps versus leading global peers. Basel Medical’s ongoing expansion and supply chain innovation offer upside, but further progress on environmental and governance disclosures is needed to reach a strong ESG standing.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Basel Medical Group Ltd Ordinary Shares. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →